CAR T Cell therapyChimeric Antigen Receptor (CAR) T-cell therapy is a revolutionary therapeutic strategy in hematologic malignancy treatment, recording high remission rates in therapy-refractory cas...
solid-tumors
CAR immune Cell therapyChimeric Antigen Receptor (CAR) immune cell therapy has transformed the treatment of cancer, especially for hematological cancers. Its effectiveness notwithstanding, it still ...
solid-tumors
May 2022: FDA approves clinical trial application of specific CAR-NK therapy FT536 in the treatment of solid tumours in a CAR-NK clinical trial. The FDA approved an Investigational New Drug Applicatio...
solid-tumors
July 2021: CAR T-Cell therapy in solid tumors has been approved in China with certain indications and markers. Recently, CAR T-Cell therapy is been tested for solid cancers like :
Breast cancer
...
solid-tumors